Metabolic cardiovascular syndrome in obese prepubertal children: The role of high fasting insulin levels

Metabolism: Clinical and Experimental

Volumn 51, Issue 4, 2002, Pages 423-428

  Valle, Miguel ^a,b,c   Gascón, Félix ^a,b,c   Martos, Rosario ^a,b,c   Ruz, Francisco Javier ^a,b,c   Bermudo, Francisco ^a,b,c   Morales, Rosario ^a,b,c   Cañete, Ramón ^a,b,c  

^a Valle de los Pedroches Hospital   (Spain)

^b Basic Primary Health Care Zone in Pozoblanco   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL; URIC ACID;

ABDOMEN; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FEMALE; GENDER; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NORMAL VALUE; OBESITY; PREDICTION; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0036113115     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.31319     Document Type: Article

References (50)

1. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease
2. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study
3. Influence of body fat distribution on free fatty acid metabolism in obesity
4. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution
5. Role of insulin resistance in human disease
6. Physical activity and metabolic cardiovascular syndrome
7. Prospective analysis of the insulin-resistance syndrome (syndrome X)
8. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels
9. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children
10. Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia
11. Association of fasting insulin with serum lipids and blood pressure in Kuwaiti children
12. Presence of metabolic cardiovascular syndrome in obese children
13. Critical periods in childhood for the development of obesity
14. Obesity
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
16. Estudio RICARDI II: Principales valores de referencia
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
18. Influence of statistical method used on the resulting estimate of normal range
19. Urate changes in lean and obese boys during pubertal development
20. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents
21. Serum alanine aminotransferase activity in obese children
22. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome
23. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study
24. Insulin resistance syndrome in adolescent
25. Insulin resistance during puberty: Results from clamp studies in 357 children
26. Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study
27. Role of insulin in regulation of high density lipoprotein metabolism
28. Lipoprotein lipase activity in skeletal muscle is related to insulin sensibility
29. Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys
30. Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study
31. Heterogeneity of human liver, muscle, and adipose tissue insulin receptor
32. Hyperuricaemia: Relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women
33. Fasting plasma insulin is an important risk factor for the development of complications in Japanese obese children. Results from a cross-sectional and longitudinal study
34. Body fat distribution and male/female differences in lipids and lipoproteins
35. The deadly quartet. Upper body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
36. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: Results from a prospective population study in Gothenburg, Sweden
37. Ultrasonic and laboratory studies on fatty liver in white-collar workers
38. Fatty liver and obesity in university students
39. The relationship between fatty liver and hyperinsulinemia in obese Japanese children
40. Association of fasting insulin with longitudinal changes in blood pressure in children and adolescents. The Bogalusa Heart Study
41. Evidence for an association of high blood pressure and hyperinsulinemia in obese man
42. Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension
43. Low sex hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden
44. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin
45. Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children
46. Infantile obesity: A situation of atherothrombotic risk?
47. Increased plasma plasminogen activator inhibitor I levels. A possible link between insulin resistance and atherothrombosis
48. Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension